Kane Financial Statements From 2010 to 2025
| KNBIF Stock | USD 0.07 0 6.76% |
Check Kane Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kane Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Kane financial statements analysis is a perfect complement when working with Kane Biotech Valuation or Volatility modules.
Kane |
Kane Biotech OTC Stock Return On Asset Analysis
Kane Biotech's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Kane Biotech Return On Asset | -0.39 |
Most of Kane Biotech's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kane Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Kane Biotech has a Return On Asset of -0.3915. This is 95.53% lower than that of the Healthcare sector and 98.34% lower than that of the Biotechnology industry. The return on asset for all United States stocks is 179.64% higher than that of the company.
Kane Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kane Biotech's current stock value. Our valuation model uses many indicators to compare Kane Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kane Biotech competition to find correlations between indicators driving Kane Biotech's intrinsic value. More Info.Kane Biotech is rated second overall in return on equity category among its peers. It is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kane Biotech's earnings, one of the primary drivers of an investment's value.About Kane Biotech Financial Statements
Kane Biotech stakeholders use historical fundamental indicators, such as Kane Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Kane Biotech investors may analyze each financial statement separately, they are all interrelated. For example, changes in Kane Biotech's assets and liabilities are reflected in the revenues and expenses on Kane Biotech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Kane Biotech. Please read more on our technical analysis and fundamental analysis pages.
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada. Kane Biotech is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Kane OTC Stock
Kane Biotech financial ratios help investors to determine whether Kane OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kane with respect to the benefits of owning Kane Biotech security.